Osome is a Fintech company based in Singapore, Singapore. It has raised $17M in total funding. Latest round: Series B.
Osome funding overview
Osome is a Fintech company based in Singapore, Singapore. Osome has raised $17M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series B announced in May 2024. The round record for Osome runs through 2024; nothing later has been disclosed. Investors on record include Target Global, XA Network, AltaIR Capital, Phystech Venture, AdFirst. 5 distinct backers are named across the disclosed rounds.
Osome at a glance
Total raised
$17M
Latest round
Series B
Latest round date
May 2024
Industry
Fintech
Headquarters
Singapore, Singapore
Notable investors
Target Global, XA Network, AltaIR Capital, Phystech Venture, AdFirst
Frequently asked about Osome funding
How much has Osome raised?
Osome has raised $17M in total disclosed funding across the rounds on record.
Who has invested in Osome?
Target Global, XA Network, AltaIR Capital, Phystech Venture, AdFirst are named among the investors backing Osome.
What was the latest Osome funding round?
The most recent disclosed round is a Series B, announced in May 2024.
Where is Osome based?
Osome is based in Singapore, Singapore.
What sector does Osome operate in?
Osome is tracked under Fintech from Singapore, Singapore, with $17M in disclosed funding.
When did Osome last raise?
The last disclosed Osome round closed in May 2024 at Series B.
Osome totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Fintech companies in Singapore below to benchmark round size and investor mix.
